Related Experiment Video
Updated: Mar 9, 2026

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
5-Flurouracil disrupts nuclear export and nuclear pore permeability in a calcium dependent manner
Kelly J Higby1,2, Melissa M Bischak1,3, Christina A Campbell1,4
1Department of Biology Hoyt Science Center 222, Westminster College, 319 S Market Street, New Wilmington, PA, 16172, USA.
Abstract:
Regulation of nuclear transport is an essential component of apoptosis. As chemotherapy induced cell death progresses, nuclear transport and the nuclear pore complex (NPC) are slowly disrupted and dismantled. 5-Fluorouracil (5-FU) and the camptothecin derivatives irinotecan and topotecan, are linked to altered nuclear transport of specific proteins; however, their general effects on the NPC and transport during apoptosis have not been characterized. We demonstrate that 5-FU, but not topotecan, increases NPC permeability, and disrupts Ran-mediated nuclear transport before the disruption of the NPC. This increased permeability is dependent on increased cellular calcium, as the Ca2+ chelator BAPTA-AM, abolishes the effect. Furthermore, increased calcium alone was sufficient to disrupt the Ran gradient. Combination treatments of 5-FU with topotecan or irinotecan, similarly disrupted nuclear transport before disassembly of the NPC. In both single and combination treatments nuclear transport was disrupted before caspase 9 activation, indicating that 5-FU induces an early caspase-independent increase in NPC permeability and alteration of nuclear transport. Because Crm1-mediated nuclear export of tumor suppressors is linked to drug resistance we also examined the effect of 5-FU on the nuclear export of a specific target, topoisomerase. 5-FU treatment led to accumulation of topoisomerase in the nucleus and recovered the loss nuclear topoisomerase induced by irinotecan or topotecan, a known cause of drug resistance. Furthermore, 5-FU retains its ability to cause nuclear accumulation of p53 in the presence of irinotecan or topotecan. Our results reveal a new mechanism of action for these therapeutics during apoptosis, opening the door to other potential combination chemotherapies that employ 5-FU as a calcium mediated inhibitor of Crm1-induced nuclear export of tumor suppressors.
Insights
5-Fluorouracil (5-FU) disrupts nuclear transport and increases nuclear pore complex (NPC) permeability via calcium, independent of caspase activation. This mechanism enhances chemotherapy efficacy by retaining tumor suppressors in the nucleus.
Area of Science:
- Cell Biology
- Molecular Biology
- Pharmacology
Background:
- Nuclear transport regulation is crucial for apoptosis and is disrupted by chemotherapy.
- The effects of 5-Fluorouracil (5-FU) and camptothecins on nuclear pore complex (NPC) function during apoptosis are not fully understood.
- Crm1-mediated nuclear export of tumor suppressors is implicated in drug resistance.
Purpose of the Study:
- To characterize the general effects of 5-FU, topotecan, and irinotecan on NPC and nuclear transport during apoptosis.
- To investigate the role of calcium and caspase activation in 5-FU-induced nuclear transport alterations.
- To examine the impact of 5-FU on the nuclear export of topoisomerase and p53, and its implications for drug resistance.
Main Methods:
- Assessed NPC permeability and Ran-mediated nuclear transport in response to 5-FU, topotecan, and irinotecan.
- Utilized the calcium chelator BAPTA-AM to investigate the role of cellular calcium.
- Examined nuclear accumulation of topoisomerase and p53 following drug treatments.
Main Results:
- 5-FU, but not topotecan, increased NPC permeability and disrupted Ran-mediated transport before NPC disassembly, dependent on increased cellular calcium.
- Increased calcium alone disrupted the Ran gradient.
- Combination treatments with 5-FU and camptothecins disrupted nuclear transport before NPC disassembly and caspase 9 activation, indicating an early, caspase-independent mechanism.
- 5-FU promoted nuclear accumulation of topoisomerase, counteracting the loss induced by irinotecan/topotecan, and retained p53 nuclear accumulation in combination treatments.
Conclusions:
- 5-FU induces an early, calcium-dependent, caspase-independent increase in NPC permeability and alters nuclear transport.
- 5-FU enhances chemotherapy efficacy by inhibiting Crm1-mediated nuclear export of tumor suppressors like topoisomerase and p53.
- These findings reveal a novel mechanism of action for 5-FU in apoptosis and suggest potential for novel combination chemotherapies.
More Related Videos
08:46Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides
Published on: July 26, 2018
12:13Rapid Identification of Chemical Genetic Interactions in Saccharomyces cerevisiae
Published on: April 5, 2015
Related Concept Videos
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Regulation of Nuclear Protein Sorting
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Directionality of Nuclear Transport
Nuclear Export of mRNA
Drugs that Destabilize Microtubules